Triad of Acute Infusion‐Related Reactions Associated with Liposomal Amphotericin B: Analysis of Clinical and Epidemiological Characteristics
Open Access
- 15 May 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (10), 1213-1220
- https://doi.org/10.1086/374553
Abstract
We investigated the clinical characteristics and treatment of patients with a distinctive triad of acute infusion-related reactions (AIRRs) to liposoKeywords
This publication has 18 references indexed in Scilit:
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000
- Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated Hemoglobin in PigsCirculation, 1999
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- Pretreatment Regimens for Adverse Events Related to Infusion of Amphotericin BClinical Infectious Diseases, 1995
- Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Clinical Studies of Liposome-Encapsulated DoxorubicinActa Oncologica, 1994
- Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin BAntimicrobial Agents and Chemotherapy, 1992
- Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durationsAntimicrobial Agents and Chemotherapy, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomesEuropean Journal of Cancer and Clinical Oncology, 1982